- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03461237
Chinese Second Hip Fracture Evaluation (CSHFE)
Second Hip Fracture Evaluation in Chinese Elderly Patients Using Quantitative Computed Tomography
- To Compare overall rates of second hip fractures in both genders,
- To determine the effect of hip fracture on proximal femoral volumetric bone mineral density (vBMD), bone structure and muscle by quantitative computed tomography(QCT),
- To evaluate the contribution of QCT-image analysis to the prediction of the second hip fracture risk.
- To identify the differences between femoral neck fracture and trochanter fracture following hip fracture
Study Overview
Status
Conditions
Detailed Description
Osteoporotic hip fracture is a great harm among elderly people, for whom disability and death often occurs. Furthermore, sustaining an osteoporotic hip fracture increases the risk of a subsequent fracture. However, the risk factors of subsequent hip fractures are less studied and the proximal femur bone structure and muscle changes following first hip fracture are little known.
Therefore, we propose to conduct an observational and perspective study to assess the effect of hip fracture on proximal femoral bone and muscle using quantitative computed tomography (QCT), as well as to evaluate the contribution of QCT-image analysis to the prediction of the second hip fracture risk. As hip fractures are divided into two major anatomic based types in clinical: femoral neck fractures (intracapsular) and trochanter fractures (extracapsular), the fundamental objective also includes identifying bone and muscle differences in a union activity between the two type fractures. Compared with duel-energy x-ray absorptiometry (DXA), QCT offers the advantage of selective measurement of the metabolically active and structurally important trabecular bone in the proximal femoral. Volumetric BMD and structure of proximal femoral and muscle around hip will be measured with QCT. The CT scanner will be the clinical CT scanner of the local participated center. Quality control and monitoring will be conducted by Beijing Jishuitan hospital, as well as the centralised image interpretation.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Yongbin Su, MD
- Phone Number: 6196 0086-010-58516688
- Email: dazaiqianyuan@126.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100035
- Recruiting
- Beijing Ji Shui Tan Hospital
-
Contact:
- Ling Wang, MD
- Phone Number: 6196 0086-010-58516688
- Email: 1988yisheng@163.com
-
Sub-Investigator:
- Ling Wang, MD
-
Sub-Investigator:
- Yimin Ma, MD
-
Sub-Investigator:
- Li Xu, MD
-
Sub-Investigator:
- yongbin Su, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- a:Osteoporotic patients b:Osteoporotic hip fracture patients (femoral neck fracture and femoral trochanteric fracture) c: Be willing to and be able to join in the study and sighed the informed consent
Exclusion Criteria:
- a:Under 47years old b:Non-surgical repair of hip fracture c:Pathologic fracture d:Violence-related trauma e:Bilateral hip implants or have hip replacement on the non-fractured side
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hip re-fracture
Time Frame: 3 years
|
The incidence and location of second hip fracture
|
3 years
|
all cause death
Time Frame: 2 year
|
all cause death
|
2 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Xiaoguang Cheng, MD, department of radiology, Beijing Jishuitan Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- JST2016CSHFE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Fractures
-
Smith & Nephew, Inc.Terminated
-
Carilion ClinicCompleted
-
Texas Tech University Health Sciences Center, El...CompletedHip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)United States
-
FH ORTHORecruitingHip Fractures | Hip DiseaseFrance
-
Zhenjiang First People's HospitalCompletedHip Fractures | Hip DiseaseChina
-
Bayside HealthCompleted
-
Oslo University HospitalDiakonhjemmet HospitalCompletedHip Fractures | Trochanteric Fractures | Intertrochanteric FracturesNorway
-
Tel-Aviv Sourasky Medical CenterUnknownIntertrochanteric Fractures of the HipIsrael
-
University of Missouri-ColumbiaUniversity of Alabama at Birmingham; Medical College of Wisconsin; University...CompletedHip Fractures | Pelvic Fractures | Acetabular FracturesUnited States
-
Rabin Medical CenterUnknown